Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Merck 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
75,000
Employees75,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
75,000
Employees75,000

MRK Key Statistics

Market cap
218.49B
Market cap218.49B
Price-Earnings ratio
13.49
Price-Earnings ratio13.49
Dividend yield
3.70%
Dividend yield3.70%
Average volume
9.28M
Average volume9.28M
High today
$88.06
High today$88.06
Low today
$87.07
Low today$87.07
Open price
$87.33
Open price$87.33
Volume
7.90M
Volume7.90M
52 Week high
$106.49
52 Week high$106.49
52 Week low
$73.31
52 Week low$73.31

MRK News

Nasdaq 13h
The Smartest Dividend Stocks to Buy With $3,000 Right Now

Need dividends? The highest-yielding stocks aren't necessarily your best choice. Quality counts. A company should not only be able to continue funding its payou...

The Smartest Dividend Stocks to Buy With $3,000 Right Now
TipRanks 1d
Schwab US Dividend Equity ETF Faces Fund Outflows

Schwab US Dividend Equity ETF ( $SCHD ) has risen by 0.15% in the past week. It has experienced a 5-day net outflow of $221.4 million. This is due, in part, to...

TipRanks 3d
Merck: FDA grants priority review for two sBLAs for Keytruda, Keytruda Qlex

Merck (MRK) announced that the U.S. FDA has granted priority review for two supplemental Biologics License Applications for Keytruda and Keytruda Qlex, each in...

Analyst ratings

55%

of 29 ratings
Buy
55.2%
Hold
44.8%
Sell
0%

More MRK News

Simply Wall St 4d
Does Merck’s 9% Rally Signal a Long-Term Value Opportunity for 2025?

Trying to decide what to do with Merck stock? You are definitely not alone. Investors all over are curious, especially after the stock’s recent moves. In just t...

Does Merck’s 9% Rally Signal a Long-Term Value Opportunity for 2025?
TipRanks 5d
Merck, Flare Therapeutics enter clinical trial collaboration, supply agreement

Flare Therapeutics entered into a clinical trial collaboration and supply agreement with Merck (MRK). FX-909, a first-in-class orally available small molecule i...

Simply Wall St 5d
Will KEYTRUDA’s New Efficacy Data and $3B Facility Change Merck’s Growth Story?

In October 2025, Merck announced a series of pivotal clinical trial results at the ESMO Congress, including long-term data showing sustained survival benefits o...

Will KEYTRUDA’s New Efficacy Data and $3B Facility Change Merck’s Growth Story?
TipRanks 6d
Neuphoria Therapeutics Ends SAD Program After Trial Failure

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 6d
Neuphoria AFFIRM-1 trial misses primary endpoint, to discontinue SAD program

Neuphoria Therapeutics (NEUP) announced that the AFFIRM-1 Phase 3 trial of BNC210 for the acute treatment of social anxiety disorder did not meet its primary en...

Nasdaq 6d
Merck Starts Construction Of $3 Bln Manufacturing Facility At Its Elkton, Virginia Site

(RTTNews) - Merck & Co., Inc. (MRK), known as MSD outside of the U.S. and Canada, announced Monday the start of construction for a $3 billion, 400,000-square-fo...

Merck Starts Construction Of $3 Bln Manufacturing Facility At Its Elkton, Virginia Site
TipRanks 6d
Merck begins construction on $3B manufacturing facility in Virginia

Merck (MRK) announced the start of construction for a $3B, 400,000-square-foot pharmaceutical manufacturing facility at its Elkton, Virginia, site. Merck’s inve...

People also own

Based on the portfolios of people who own MRK. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.